Search

Platelet-activating factor (PAF), a lipid mediator of inflammation and anaphylaxis, may play a role in several physiopathologic alterations of the lung. A lipid compound with physicochemical and biologic characteristics similar to synthetic PAF was extracted and purified from bronchoalveolar lavage (BAL) fluid of 15 of 34 patients with sarcoidosis. PAF was quantitated by a bioassay on washed rabbit platelets. The specificity of platelet aggregation was assessed by using two different PAF receptor antagonists. The incidence of detectable amounts of PAF in BAL fluid of sarcoid patients was statistically significant (chi 2 = 4.064, p = 0.044) when compared with the 14 normal control subjects. The results demonstrated an increased production of PAF in the lower respiratory tract of patients with sarcoidosis. The presence of PAF in BAL fluid, however, did not correlate with radiologic stage, intensity of alveolitis, gallium scanning positivity, angiotensin-converting enzyme serum level, or lung function tests. Therefore, a direct relationship between presence of PAF in BAL fluid and activity of lung disease in patients with sarcoidosis was not directly established.

175 sera from children and 101 sera from adults both with respiratory illness of unknown origin were collected between September 1980 and February 1983 and studied by using the indirect immunofluorescence test for Legionnaires' disease. By using the criteria of the Center for Disease Control for a positive (fourfold increase in titer over 128 during convalescence) or presumptive (single titer greater than or equal to 256) serological test, 8 samples from adults (7.92%) and 11 samples from children (6.27%) gave a positive result. These results suggest that the frequency of Legionnaires' disease is similar in both adults and children.